Skip to content

ACR | LAB Urine Analysis Test System Evaluation of Performance

A Comparative, Controlled Study to Evaluate the Performance of the ACR | LAB Urine Analysis Test System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04466501
Enrollment
375
Registered
2020-07-10
Start date
2019-06-30
Completion date
2019-09-30
Last updated
2020-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Hypertension

Brief summary

The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an image recognition algorithm. The degree of agreement of the ACR \| LAB as compared to the comparator device will be tested. Urine samples will be tested by a separate professional user on each device.

Interventions

DEVICEACR LAB

The ACR \| LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The device combines a urine stick kit with an easy to use smartphone application using an image recognition algorithm.

Sponsors

Healthy.io Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women 18-80 years of age; * Subjects who are healthy or pregnant; or * Subjects diagnosed with a disease that normally represents itself with an abnormal concentration of albumin: * Diabetes Type I/Type II, * Hypertension, * Any kidney disease, * Other relevant conditions. * Subjects with any pathological findings which might be identified by the urine test (according to the physician discretion); * Subject is capable and willing to provide informed consent; * Subject has facility with both hands * Subject is capable and willing to adhere to the study procedures.

Design outcomes

Primary

MeasureTime frame
Evaluate the performance agreement of the ACR |LAB compared to the comparator device, tested by professional users.11 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026